Comprehensive assessment of blood–brain barrier opening and sterile inflammatory response: unraveling the therapeutic window
Scientific Reports · 2024
DOI: 10.1038/s41598-024-67916-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Payton J Martinez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering Program, University of Colorado Boulder, Boulder, CO, 80303, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Microbubbles, Inflammation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Microbubbles (MBs) combined with focused ultrasound (FUS) has emerged as a promising noninvasive technique to permeabilize the blood-brain barrier (BBB) for drug delivery into the brain. However, the safety and biological consequences of BBB opening (BBBO) remain incompletely understood. This study aims to investigate the effects of two parameters mediating BBBO: microbubble volume dose (MVD) and mechanical index (MI). High-resolution MRI-guided FUS was employed in mouse brains to assess BBBO by manipulating these two parameters. Afterward, the sterile inflammatory response (SIR) was studied 6 h post-FUS treatment. Results demonstrated that both MVD and MI significantly influenced the extent of BBBO, with higher MVD and MI leading to increased permeability. Moreover, RNA sequencing revealed upregulation of major inflammatory pathways and immune cell infiltration after BBBO, indicating the presence and extent of SIR. Gene set enrichment analysis identified 12 gene sets associated with inflammatory responses that were significantly upregulated at higher MVD or MI. A therapeutic window was established between therapeutically relevant BBBO and the onset of SIR, providing operating regimes to avoid damage from stimulation of the NFκB pathway via TNFɑ signaling to apoptosis. These results contribute to the optimization and standardization of BBB opening parameters for safe and effective drug delivery to the brain and further elucidate the underlying molecular mechanisms driving sterile inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Engineering Program, University of Colorado Boulder, Boulder, CO, 80303, USA.
- Department of Radiology, Cancer Center Animal Imaging Shared Resource, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
- Department of Mechanical Engineering, University of Colorado Boulder, Boulder, CO, 80303, USA.
- Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
- Alpheus Medical, Inc., 1266 Park Rd., Chanhassen, MN, 55317, USA.
- Biomedical Engineering Program, University of Colorado Boulder, Boulder, CO, 80303, USA. mark.borden@colorado.edu.
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Martinez, P. J., Song, J. J., Garay, F. G., Song, K. H., Mufford, T., Steiner, J., DeSisto, J., Ellens, N., Serkova, N. J., Green, A. L., & Borden, M. (2024). Comprehensive assessment of blood–brain barrier opening and sterile inflammatory response: unraveling the therapeutic window. Scientific Reports. https://doi.org/10.1038/s41598-024-67916-8
Vancouver
Martinez PJ, Song JJ, Garay FG, Song KH, Mufford T, Steiner J, et al. Comprehensive assessment of blood–brain barrier opening and sterile inflammatory response: unraveling the therapeutic window. Scientific Reports. 2024. doi:10.1038/s41598-024-67916-8
BibTeX
@article{Martinez2024,
author = {Martinez, Payton J and Song, Jane J and Garay, Francis G and Song, Kang-Ho and Mufford, Toni and Steiner, Jenna and DeSisto, John and Ellens, Nicholas and Serkova, Natalie J and Green, Adam L and Borden, Mark},
title = {Comprehensive assessment of blood–brain barrier opening and sterile inflammatory response: unraveling the therapeutic window},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-67916-8}
}
EUVIMED